Publicaciones en las que colabora con Rafael Marcos Gragera (57)

2024

  1. Burden of postmenopausal breast cancer attributable to excess body weight: comparative study of body mass index and CUN-BAE in MCC-Spain study

    Journal of Epidemiology and Community Health

  2. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study

    The Lancet Oncology, Vol. 25, Núm. 3, pp. 293-307

  3. Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study

    The Lancet Oncology, Vol. 25, Núm. 6, pp. 731-743

2023

  1. Cancer data quality and harmonization in Europe: the experience of the BENCHISTA Project – international benchmarking of childhood cancer survival by stage

    Frontiers in Oncology, Vol. 13

  2. Childhood and Adolescent Central Nervous System Tumours in Spain: Incidence and Survival over 20 Years: A Historical Baseline for Current Assessment

    Cancers, Vol. 15, Núm. 24

  3. Circulating miRNAs signature on breast cancer: the MCC-Spain project

    European Journal of Medical Research, Vol. 28, Núm. 1

  4. Consumption of aspartame and other artificial sweeteners and risk of cancer in the Spanish multicase-control study (MCC-Spain)

    International Journal of Cancer, Vol. 153, Núm. 5, pp. 979-993

  5. Global survival trends for brain tumors, by histology: Analysis of individual records for 67,776 children diagnosed in 61 countries during 2000-2014 (CONCORD-3)

    Neuro-Oncology, Vol. 25, Núm. 3, pp. 593-606

  6. Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000–2014 (CONCORD-3)

    Neuro-Oncology, Vol. 25, Núm. 3, pp. 580-592

  7. Incidence and time trends of childhood hematological neoplasms: a 36-year population-based study in the southern European context, 1983–2018

    Frontiers in Oncology, Vol. 13

2022

  1. Association of time of breakfast and nighttime fasting duration with breast cancer risk in the multicase-control study in Spain

    Frontiers in Nutrition, Vol. 9

  2. Cancer Survival in Adults in Spain: A Population-Based Study of the Spanish Network of Cancer Registries (REDECAN)

    Cancers, Vol. 14, Núm. 10

  3. Differences in breast cancer-risk factors between screen-detected and non-screen-detected cases (MCC-Spain study)

    Cancer Causes and Control, Vol. 33, Núm. 1, pp. 125-136

  4. Effect of the use of prediagnosis hormones on breast cancer prognosis: MCC-Spain study

    Menopause (New York, N.Y.), Vol. 29, Núm. 11, pp. 1315-1322

  5. Incidence and survival of lymphoid neoplasms in Spain, 2002-2013: A population-based study from the Spanish Network of Cancer Registries (REDECAN)

    Frontiers in Oncology, Vol. 12

  6. Incidence of myeloid neoplasms in Spain (2002–2013): a population-based study of the Spanish network of cancer registries

    Scientific Reports, Vol. 12, Núm. 1

  7. Proportion and stage distribution of screen-detected and non-screen-detected colorectal cancer in nine European countries: an international, population-based study

    The Lancet Gastroenterology and Hepatology, Vol. 7, Núm. 8, pp. 711-723

  8. Sleep and breast and prostate cancer risk in the MCC-Spain study

    Scientific Reports, Vol. 12, Núm. 1

  9. Toenail zinc as a biomarker: Relationship with sources of environmental exposure and with genetic variability in MCC-Spain study

    Environment International, Vol. 169

  10. Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries

    The Lancet Child and Adolescent Health, Vol. 6, Núm. 6, pp. 409-431